SBIR/STTR Research Award
Multiplexed Diagnostic Platform for Invasive Fungal Infection
Award amount
$1,299,985Program and phase
SBIR · Phase IIAward year
2025Award details
- Awarding agency
- Department of Defense
- Branch
- Defense Health Agency
- Recipient company
- EMERGINGDX INC
- Proposal award date
- 2025-02-05
- Contract end date
- 2027-06-04
- UEI
- C1LMYC2AY934
- Solicitation number
- 23.3
- Topic code
- DHA233-001
Research abstract
EmergingDx in collaboration with its academic and industrial partners will further develop its novel rapid diagnostic platform for detection of invasive fungal infection (IFI). The core technology involves a self-contained multiplexed microfluidic cartridge with very sensitive sensors and a reader that can detect and speciate invasive fungal wound infections from a biomatrix.
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
- Autonomous Soft Robot for Locomotion in Granular Seabed Media
- Rapid, Automated, Multiplexed Omics Platform
- Integrated Multiplexed Low-Cost Diagnostic Platform for Rapid Microbial Identification
- Rapid, Automated, Multiplexed Omics Platform
- Automated Detection Platform of Circulating and Exosomal miRNAs
Awards with the same topic code
Verified by an exact topic code match. This is not a text-similarity match.
- Multiplexed Diagnostic Platform for Invasive Fungal Infection
- Expanding GeneCaptureÆs Rapid Portable IFI Diagnostic for Wound Infections
Research funding history
12 SBIR/STTR records share this UEI (2023–2025). Reported award amounts total $6,696,877. Reported amounts are not federal obligations.
Phases: Phase I, Phase II
Agencies: Department of Defense, Department of Agriculture